Common Contracts

AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

Registration Rights Agreement • September 29th, 2021 • Amplitude Healthcare Acquisition Corp • Biological products, (no disgnostic substances) • New York

• Contract Type
  Registration Rights Agreement
• Filed
  September 29th, 2021
• Company
  Amplitude Healthcare Acquisition Corp
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of September 24, 2021, is made and entered into by and among Jasper Therapeutics, Inc. (f/k/a Amplitude Healthcare Acquisition Corporation), a Delaware corporation (the “Company”), Amplitude Healthcare Holdings LLC, a Delaware limited liability company (the “Sponsor”), and certain former stockholders of Jasper Therapeutics, Inc., a Delaware corporation (“Jasper”), set forth in Schedule 1 hereto (such stockholders, the “Jasper Holders”, together with the Sponsor and any person or entity who hereafter becomes a party to this Agreement pursuant to Section 6.2 of this Agreement, a “Holder” and collectively the “Holders”). Capitalized terms used but not otherwise defined in this Agreement shall have the meanings ascribed to such terms in the Business Combination Agreement (as defined below).

FORM OF AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

Registration Rights Agreement • May 6th, 2021 • Amplitude Healthcare Acquisition Corp • Blank checks • New York

• Contract Type
  Registration Rights Agreement
• Filed
  May 6th, 2021
• Company
  Amplitude Healthcare Acquisition Corp
• Industry
  Blank checks
• Jurisdiction
  New York

THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of [●], 2021, is made and entered into by and among Jasper Therapeutics, Inc. (f/k/a Amplitude Healthcare Acquisition Corporation), a Delaware corporation (the “Company”), Amplitude Healthcare Holdings LLC, a Delaware limited liability company (the “Sponsor”), and certain former stockholders of Jasper Therapeutics, Inc., a Delaware corporation (“Jasper”), set forth in Schedule 1 hereto (such stockholders, the “Jasper Holders”, together with the Sponsor and any person or entity who hereafter becomes a party to this Agreement pursuant to Section 6.2 of this Agreement, a “Holder” and collectively the “Holders”). Capitalized terms used but not otherwise defined in this Agreement shall have the meanings ascribed to such terms in the Business Combination Agreement (as defined below).